Abstract
Eight strans of ampicillin-resistant beta-lactamase-producing Haemophilus influenzae type b were studied in vitro for synergy between amoxicillin and clavulanic acid. The minimal inhibitory concentrations for amoxicillin alone were 6.25 to 12.5 microgram/ml, and for clavulanic acid alone they were 12.5 to 25 microgram/ml. However, seven of eight strains were inhibited by a combination of 0.36 microgram of amoxicillin and 0.36 microgram of clavulanic acid per ml. Infant rat models of bacteremia and meningitis were used to test the efficacy of amoxicillin and clavulanic acid alone and in combination upon four strains of ampicillin-resistant H. influenzae. Neither amoxicillin alone (27 animals) nor clavulanic acid alone (20 animals) sterilized the blood or cerebrospinal fluid of the animals. In contrast, 30 of 33 blood cultures and 29 of 33 cerebrospinal fluid cultures were sterile when a combination of the two drugs in the same dosages was used. The observed in vitro and in vivo synergism between amoxicillin and clavulanic acid suggests that the combination may be effective therapy for invasive infections in humans caused by ampicillin-resistant H. influenzae type b.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ball A. P., Geddes A. M., Davey P. G., Farrell I. D., Brookes G. R. Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study. Lancet. 1980 Mar 22;1(8169):620–623. doi: 10.1016/s0140-6736(80)91118-6. [DOI] [PubMed] [Google Scholar]
- Charnas R. L., Fisher J., Knowles J. R. Chemical studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid. Biochemistry. 1978 May 30;17(11):2185–2189. doi: 10.1021/bi00604a025. [DOI] [PubMed] [Google Scholar]
- Farrar W. E., Jr, O'Dell N. M. Beta-lactamase activity in ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother. 1974 Nov;6(5):625–629. doi: 10.1128/aac.6.5.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fisher J., Charnas R. L., Knowles J. R. Kinetic studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid. Biochemistry. 1978 May 30;17(11):2180–2184. doi: 10.1021/bi00604a024. [DOI] [PubMed] [Google Scholar]
- Matsuura M., Nakazawa H., Hashimoto T., Mitsuhashi S. Combined antibacterial activity of amoxicillin with clavulanic acid against ampicillin-resistant strains. Antimicrob Agents Chemother. 1980 Jun;17(6):908–911. doi: 10.1128/aac.17.6.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sykes R. B., Matthew M., O'Callaghan C. H. R-factor mediated beta-lactamase production by Haemophilus influenzae. J Med Microbiol. 1975 Aug;8(3):437–441. doi: 10.1099/00222615-8-3-437. [DOI] [PubMed] [Google Scholar]
- Van Klingeren B., Dessens-Kroon M. The influence of clavulanic acid on the susceptibility to amoxycillin of beta-lactamase producing strains of H. influenzae using different inoculum sizes. J Antimicrob Chemother. 1979 May;5(3):322–323. doi: 10.1093/jac/5.3.322. [DOI] [PubMed] [Google Scholar]
- Yogev R., Burkholder E., Davis A. T. Synergistic action of ampicillin and nafcillin against ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother. 1980 Mar;17(3):461–463. doi: 10.1128/aac.17.3.461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yogev R., Kabat W. J. Synergistic action of nafcillin and ampicillin against ampicillin-resistant Haemophilus influenzae type b bacteremia and meningitis in infant rats. Antimicrob Agents Chemother. 1980 Jul;18(1):122–124. doi: 10.1128/aac.18.1.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yogev R. Soft-tissue infections of ampicillin-resistant Haemophilus influenzae type b. The use of ampicillin and nafcillin in their treatment. Am J Dis Child. 1981 May;135(5):410–412. doi: 10.1001/archpedi.1981.02130290008003. [DOI] [PubMed] [Google Scholar]